
Copper-tripeptide discovered in human plasma — master dermal regenerator. Declines with age and is key in skin and hair repair.
Ranges cited in research literature. Not a usage recommendation. For research use only.
GHK-Cu is the complex between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. Loren Pickart isolated it from human plasma in 1973 after observing that plasma from young people made liver tissue from older people behave young in culture. Its plasma concentration falls sharply between ages 20 and 60, and that decline is one reason it is studied in skin aging and tissue repair. The copper is part of the active molecule, not a contaminant.
In dermal fibroblasts it increases the synthesis of collagen, elastin, decorin and glycosaminoglycans while also regulating metalloproteinases and their inhibitors, which makes it a modulator of remodeling rather than a simple stimulator. Gene-expression analyses from the Broad Institute (Connectivity Map) showed it alters the activity of thousands of genes, reversing signatures associated with lung cancer, COPD and aging in cell models. It is also an indirect antioxidant and a chelator of free copper.
Human evidence is topical: creams and serums with GHK-Cu have shown improvement in firmness, wrinkles and dermal density in controlled trials of moderate size, and formulations exist for wounds and post-laser care. The injectable route used by the research market has no clinical trials. The reconstituted solution should be blue; if the color fades, the copper has dissociated and the complex is no longer intact. Renova distributes it for research only.
| Class | Endogenous tripeptide–copper(II) complex (human plasma) |
| Sequence | Gly-His-Lys · Cu(II) (1:1 ratio) |
| CAS | 49557-75-7 (GHK-Cu) · 72957-37-0 (free GHK) |
| Discovery | Loren Pickart, 1973 (human plasma) |
| Actions studied | Collagen, elastin, decorin; MMP/TIMP balance; gene expression; indirect antioxidant |
| Human evidence | Topical (controlled skin trials); injectable route research only |
| Visual quality check | Light-blue solution; colorless or greenish = dissociated copper |
| Renova presentations | 50 mg and 100 mg vials; component of GLOW and KLOW |
Because copper(II) coordinated to the tripeptide absorbs red light and lets blue through. The color is part of quality control: a correct GHK-Cu solution is light blue; if it turns colorless, the copper has separated from the peptide and the complex is no longer the compound that was studied.
GHK is the tripeptide without metal; GHK-Cu is the copper(II) complex, the form that circulates in plasma and carries most of the activity described in the literature. The copper is not an additive: it is part of the active molecule.
Topical. The controlled human trials on firmness, wrinkles and dermal density were done with creams and serums. The injectable route has no clinical trials and in Renova's context is strictly research; our product page also notes it must not be injected in the face.
Because the literature on GHK-Cu in dermal matrix uses far larger amounts than those of the repair peptides it is combined with; hence the blends carry 50 mg of GHK-Cu against 10 mg of each of the other components.
Related reading: GHK-Cu: Copper-Tripeptide, Dermal Regenerator & Senescence · GLOW vs KLOW: Which Repair Blend to Choose
Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.
Your cart is empty